Gain Therapeutics, Inc. SEC filings GANX
Gain Therapeutics, Inc. has 240 filings in SEC EDGAR's recent list, going back to Jul 30, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Dec 3, 2025 | — |
| 424B5 | Prospectus supplement | Nov 28, 2025 | — |
| S-3/A | Filing | Nov 7, 2025 | — |
| 424B5 | Prospectus supplement | Jul 17, 2025 | — |
| 424B5 | Prospectus supplement | Jul 15, 2025 | — |
| S-3 | Shelf registration | May 28, 2025 | — |
| S-8 | Employee stock plan registration | Sep 19, 2024 | — |
| 424B5 | Prospectus supplement | Sep 6, 2024 | — |
| FWP | Free writing prospectus | Jul 1, 2024 | — |
| 424B5 | Prospectus supplement | Jun 17, 2024 | — |
| 424B5 | Prospectus supplement | Jun 13, 2024 | — |
| 424B3 | Prospectus | Jan 2, 2024 | — |
| S-1 | Registration statement | Dec 19, 2023 | — |
| 424B5 | Prospectus supplement | Nov 24, 2023 | — |
| 424B5 | Prospectus supplement | Nov 20, 2023 | — |
| S-8 | Employee stock plan registration | May 30, 2023 | — |
| S-8 | Employee stock plan registration | Jul 15, 2022 | — |
| S-3/A | Filing | May 23, 2022 | — |
| S-3 | Shelf registration | May 18, 2022 | — |
| S-8 | Employee stock plan registration | Apr 6, 2021 | — |
| 424B4 | Prospectus | Mar 22, 2021 | — |
| S-1/A | Amended registration statement | Mar 15, 2021 | — |
| S-1/A | Amended registration statement | Mar 10, 2021 | — |
| S-1 | Registration statement | Feb 19, 2021 | — |
Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GANX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bethesda, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1819411
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.